Tirzepatide for MASH with fibrosis 15 mg produced a large majority disease-resolution rate versus a small placebo rate: Loomba NEJM 2024 (SYNERGY-NASH)
We serve patients from Laurel MD, Maryland City MD, South Laurel MD, Ammendale MD, Savage MD, and surrounding areas
Why Women in Midlife May Be Especially Tempted by BPC-157 Social media is filled with images from midlife peptide influencers (yes, thats a thing) who have your same achy joints, weird pains, and injuries that are slow to heal
Diabetic Medicine, 28 (8), 972975
Soszyski M et al
In response to inflammatory mediators, ECs produce pro-inflammatory cytokines and chemokines such as IL-1, IL-6, CCL2, and CXCL1, and synthesize ICAM-1 and VCAM-1, facilitating the infiltration of immune cells [239]